INDIANAPOLIS, Sept. 1, 2011 /PRNewswire/ -- Roche Diabetes Care, makers of the ACCU-CHEK® portfolio of diabetes management products and services, is proud to host its second annual Infusion Site Awareness Week, Aug. 29-Sept. 4, a week-long effort to highlight the importance of proper infusion site management for the 400,000 people in the United States with Type 1 diabetes who use an insulin pump.
"The inaugural Infusion Site Awareness Week, which was launched during the 2010 annual American Association of Diabetes Educators (AADE) conference, helped us reach hundreds of diabetes educators and people living with Type 1 diabetes who are now better able to identify and address potential complications stemming from improper site management," said Roche Diabetes Care North America Medical Director Andreas Stuhr, M.D.
According to the Juvenile Diabetes Research Foundation (JDRF), a supporting partner for this year's campaign, as many as 3 million Americans live with type 1 diabetes, and about 15,000 children and 15,000 adults are diagnosed with the disease every year.
"Living with type 1 diabetes requires a person to be extremely aware and knowledgeable about the disease," said Aaron Kowalski, Ph.D., Assistant Vice President of Treatment Therapies for JDRF. "In addition to monitoring blood sugar and adjusting diet and exercise, proper infusion site rotation and care is an often underemphasized, but very important part of good diabetes management. Infusion Site Awareness Week is a perfect opportunity for diabetes educators to discuss the importance of best practices for insulin pump usage with their patients, both new and old."
For people with diabetes using insulin pump therapy, the infusion site is where an insulin pump's plastic cannula or steel needle is placed under the user's skin to administer insulin. Infusion site management is the practice of choosing a site, cleaning and preparing it, properly inserting a cannula or ne